Impact of First-Line Osimertinib and Other EGFR-Tyrosine Kinase Inhibitors on Overall Survival in Untreated Advanced EGFR-Mutated Non-small Cell Lung Cancer in Japan: Updated Data from TREAD Project 01.

Detalles Bibliográficos
Publicado en:	Targeted Oncology Vol. 19; no. 6; pp. 925 - 940
Autores principales:	Hibino, Makoto, Imamura, Yoshinori, Shimoyama, Rai, Fukui, Tomoya, Fukai, Ryuta, Iwase, Akihiko, Tamura, Yukihiro, Chihara, Yusuke, Okabe, Takafumi, Uryu, Kiyoaki, Okuda, Tadahisa, Taguri, Masataka, Minami, Hironobu
Formato:	Journal Article
Publicado:	Springer Nature Nov2024
Acceso en línea:	Ver este registro en EBSCOhost

Descripción
Descripción no disponible.